Effects of Glycosaminoglycans on Experimental Urolithiasis in Rats
It has been suggested that the glycosaminoglycans (GAGs) heparan sulfate (HS) and chondroitin sulfate (CS) inhibit calcium oxalate (CaOx) crystallization in vitro 1. Moreover we have previously found that stone forming subjects excrete lower levels of GAGs compared to non-stone formers2. Thus, since GAGs may inhibit calculi growth in vivo, we tested the effect of administering CS to rats using an experimental model of lithiasis.
KeywordsUrinary Excretion Heparan Sulfate Chondroitin Sulfate Calcium Oxalate Urinary Stone
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
WG Robertson, M Peacock, BEC Nordin, Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro, Clin Chim Acta
43: 31 (1973).PubMedCrossRefGoogle Scholar
YM Michelacci, RQ Clashan, N Schor, Urinary excretion of glycosaminoglycans in normal and stone forming subjects, Kidney Int
36: 1022 (1989).PubMedCrossRefGoogle Scholar
JL Meyer, LH Smith, Growth of calcium oxalate crystals. I. Model of urinary stone growth. Invest Urol
13: 31 (1975).PubMedGoogle Scholar
© Springer Science+Business Media New York 1994